Holen Sie sich die Stockscreener-App
439.29
0.26%
1.1925
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ISRG?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$438.10
Offen:
$439.42
24-Stunden-Volumen:
939.36K
Relative Volume:
0.48
Marktkapitalisierung:
$155.51B
Einnahmen:
$10.58B
Nettoeinkommen (Verlust:
$3.00B
KGV:
53.29
EPS:
8.2437
Netto-Cashflow:
$2.83B
1W Leistung:
-0.53%
1M Leistung:
-8.92%
6M Leistung:
-23.51%
1J Leistung:
-18.59%
1-Tages-Spanne:
$434.15
$442.94
1-Wochen-Bereich:
$434.15
$449.77
52-Wochen-Spanne:
$417.74
$603.88
Intuitive Surgical Inc Stock (ISRG) Company Profile
Firmenname
Intuitive Surgical Inc
Sektor
Telefon
(408) 523-2100
Adresse
1020 KIFER ROAD, SUNNYVALE
Compare ISRG vs BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
439.10 | 155.16B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
148.80 | 40.68B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.63 | 33.06B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
36.11 | 31.30B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
209.00 | 30.18B | 5.54B | 1.52B | 1.74B | 10.37 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2026-01-27 | Eingeleitet | TD Cowen | Buy |
| 2025-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-07-23 | Herabstufung | Erste Group | Buy → Hold |
| 2025-06-09 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2025-06-05 | Hochstufung | Erste Group | Hold → Buy |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-02 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-07-10 | Bestätigt | Citigroup | Buy |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2023-11-17 | Eingeleitet | HSBC Securities | Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-04-19 | Bestätigt | BTIG Research | Buy |
| 2023-04-19 | Bestätigt | BofA Securities | Buy |
| 2023-04-19 | Bestätigt | Citigroup | Buy |
| 2023-04-19 | Bestätigt | Evercore ISI | In-line |
| 2023-04-19 | Bestätigt | JP Morgan | Overweight |
| 2023-04-19 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2023-04-19 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-04-19 | Bestätigt | Raymond James | Outperform |
| 2023-04-19 | Bestätigt | Stifel | Buy |
| 2023-04-19 | Bestätigt | Truist | Buy |
| 2023-04-19 | Bestätigt | Wells Fargo | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-03-23 | Eingeleitet | William Blair | Outperform |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-13 | Eingeleitet | Mizuho | Neutral |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-03-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-31 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-01-25 | Herabstufung | Redburn | Buy → Neutral |
| 2022-01-21 | Bestätigt | BTIG Research | Buy |
| 2022-01-21 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-01-21 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-21 | Bestätigt | Evercore ISI | In-line |
| 2022-01-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-01-21 | Bestätigt | Piper Sandler | Neutral |
| 2022-01-21 | Bestätigt | Raymond James | Outperform |
| 2022-01-21 | Bestätigt | Robert W. Baird | Outperform |
| 2022-01-21 | Bestätigt | Stifel | Buy |
| 2022-01-21 | Bestätigt | UBS | Neutral |
| 2022-01-21 | Bestätigt | Wells Fargo | Overweight |
| 2022-01-10 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-10-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-07-21 | Bestätigt | BofA Securities | Neutral |
| 2021-07-21 | Bestätigt | Citigroup | Buy |
| 2021-07-21 | Bestätigt | JP Morgan | Overweight |
| 2021-07-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-07-21 | Bestätigt | Piper Sandler | Neutral |
| 2021-07-21 | Bestätigt | SVB Leerink | Mkt Perform |
| 2021-07-21 | Bestätigt | Stifel | Buy |
| 2021-07-21 | Bestätigt | UBS | Neutral |
| 2021-07-21 | Bestätigt | Wells Fargo | Overweight |
| 2021-07-14 | Bestätigt | Goldman | Buy |
| 2021-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-04-21 | Hochstufung | Oppenheimer | Underperform → Perform |
| 2021-04-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-04-01 | Eingeleitet | Citigroup | Buy |
| 2020-12-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-09-28 | Eingeleitet | Argus | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-09-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-07-20 | Bestätigt | Bernstein | Outperform |
| 2020-04-28 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-04-17 | Herabstufung | CFRA | Hold → Sell |
| 2020-04-17 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-09 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-04-01 | Herabstufung | Oppenheimer | Perform → Underperform |
| 2020-01-27 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-12-12 | Bestätigt | Wells Fargo | Outperform |
| 2019-11-21 | Eingeleitet | Oppenheimer | Perform |
| 2019-07-19 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-22 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-02 | Eingeleitet | Deutsche Bank | Buy |
| 2018-10-31 | Bestätigt | Piper Jaffray | Overweight |
| 2018-10-19 | Hochstufung | Canaccord Genuity | Hold → Buy |
Alle ansehen
Intuitive Surgical Inc Aktie (ISRG) Neueste Nachrichten
Intuitive Surgical (ISRG) Announces Several Innovations to Advance Quintuple Aim - Yahoo Finance
Is Intuitive Surgical (ISRG) One of the Best Robotic Surgery Stocks to Buy? - Insider Monkey
Intuitive Surgical stock (US46120E6023): Robotic surgery leader digests post-earnings pullback - AD HOC NEWS
ISRG's Ion Platform: A Major Growth Engine in Lung Cancer Care? - Yahoo Finance
Intuitive Surgical, Inc. stock (US46120E6023): Q1 growth highlights da Vinci strength while shares c - AD HOC NEWS
Intuitive Surgical Fell 9% Over the Last 30 Days. Here’s Where the Stock Is Headed in 2026 - TIKR.com
Intuitive surgical EVP Mark Brosius sells $15,945 in stock By Investing.com - Investing.com Nigeria
Why is Intuitive Surgical (ISRG) down 7.2% since last earnings report? - MSN
Intuitive Surgical, Inc. stock (US46120E6023): Da Vinci maker grows on strong procedure demand - AD HOC NEWS
Insider Sell Alert: Mark Brosius Sells Shares of Intuitive Surgi - GuruFocus
Intuitive surgical EVP Mark Brosius sells $15,945 in stock - Investing.com
Intuitive Surgical (ISRG) EVP Brosius sells 36 shares in planned trades - Stock Titan
Intuitive readies 100 updates and improvements for da Vinci 5 - MedTech Dive
Zacks Industry Outlook Highlights Electromed, Globus Medical and Intuitive Surgical - TradingView
Wells Fargo Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $654 - Moomoo
ISRG Stock Price, Quote & Chart | INTUITIVE SURGICAL INC (NASDAQ:ISRG) - ChartMill
3 Big Reasons ISRG Should Be On Your Watchlist - Yahoo Finance
Intuitive Surgical’s Da Vinci 5 Upgrades Aim To Deepen Moat For Investors - Yahoo Finance
Are Wall Street Analysts Bullish on Intuitive Surgical Stock? - Barchart.com
Precision Trading with Intuitive Surgical Inc. (ISRG) Risk Zones - Stock Traders Daily
Intuitive Surgical Inc. stock underperforms Thursday when compared to competitors - MarketWatch
2 Most Compelling Stocks to Buy for Long‑Term Investors Right Now - The Motley Fool
Intuitive Surgical stock (US46120E6023): insider sale and long?term growth story in focus - AD HOC NEWS
Why Is Intuitive Surgical (ISRG) Down 7.2% Since Last Earnings Report? - Yahoo Finance
Intuitive Unveils Da Vinci 5 Ecosystem Enhancements - Medical Product Outsourcing
Intuitive announces da Vinci 5 updates, extended instrument use By Investing.com - Investing.com Canada
Intuitive Announces Innovations to Advance Quintuple Aim - Scott Coop
ISRG's SP Platform: Early-Stage Growth or Next TAM Expansion Driver? - TradingView
Insider Sell: Mark Brosius Sells Shares of Intuitive Surgical In - GuruFocus
Intuitive surgical EVP Brosius sells $23,463 in company stock - Investing.com
Intuitive Surgical (NASDAQ: ISRG) EVP sells 54 shares via Rule 10b5-1 plan - Stock Titan
Intuitive Surgical (ISRG) Q1 2026 Earnings Call Transcript - Fortune
Intuitive Surgical Inc. stock outperforms competitors on strong trading day - MarketWatch
Intuitive Surgical stock (US46120E6023): da Vinci maker in focus after latest earnings and analyst u - AD HOC NEWS
North America Minimally Invasive Surgery Robot Market Worth US$ - openPR.com
Investors heavily search Intuitive Surgical, Inc. (ISRG): Here is what you need to know - MSN
Silver Economy Investing: Why the Healthcare Giants Are in Focus - TradingView
Robotics expert Brian Miller on product development, AI and what he learned at Intuitive - Medical Design & Outsourcing
Intuitive Surgical stock (US46120E6023): robot-assisted surgery leader in focus after latest quarter - AD HOC NEWS
Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know - Yahoo Finance
ISRG DCF Analysis: Intrinsic Value $196 vs Price $440 - GuruFocus
Intuitive Surgical stock (US46120E6023): robot-assisted surgery leader after latest earnings - AD HOC NEWS
Intuitive Surgical Inc (ISRG) Stock Price, Trades & News - GuruFocus
Is It Too Late to Buy Intuitive Surgical Inc (ISRG) After 4.5% Rally? GF Value Says Undervalued - GuruFocus
Assessing Intuitive Surgical (ISRG) Valuation After The Recent Share Price Pullback - Yahoo Finance
Intuitive Surgical Price Target Cut to $520.00/Share From $650.00 by B of A Securities - Moomoo
Intuitive Surgical Inc Stock (ISRG) Moved Up by 3.76% on May 18: A Full Analysis - TradingKey
Here is what to know beyond why Intuitive Surgical, Inc. (ISRG) is a trending stock - MSN
Intuitive Surgical, Inc. Stock 12‑Month Price Target Cut to $577.87, Implies 37% Upside - TradingView
North Dakota State Investment Board Invests $6.93 Million in Intuitive Surgical, Inc. $ISRG - MarketBeat
Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring A Potential 37% Upside - DirectorsTalk Interviews
Finanzdaten der Intuitive Surgical Inc-Aktie (ISRG)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.57%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):